Kyntra Bio KYNB
NASDAQ KYNB
$3.20 -0.29 (-8.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Kyntra Bio (KYNB) Change in Intangibles (2021 - 2022)

Updated

Kyntra Bio's Change in Intangibles was $35 million in FY2022, up 40.0% from $25 million in FY2021.

Analysis

Kyntra Bio (KYNB) Change in Intangibles (2021 - 2022) Analysis & Trends

  • Per Business Quant data, Change in Intangibles in earlier years was $25 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Intangibless (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.06 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 995.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -7.20 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Kyntra Bio 12.57 Mn -395.37 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 35.00 Mn
Sep 30, 2021 25.00 Mn
API Access

Kyntra Bio Change in Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-intangibles&ticker=KYNB&period=max&api_key=YOUR_API_KEY